Company news
Coiled Therapeutics PLC news in 2022
Coiled Therapeutics PLC's news releases, calls and decks from 2022, newest first.
Presentation of Midkine Oligonucleotide Program
December 5, 2022
Resignation of Auditor
December 1, 2022
Midkine Antibody Program - Festival of Biologics
October 25, 2022
ROQ Presents Study Results at the ESGCT Conference
October 11, 2022
Interim Results to 30 June 2022
September 23, 2022
Board and Management Appointments
September 16, 2022
Notice of Admission
September 15, 2022
Publication of Prospectus
September 13, 2022
Pre-clinical Program & Transaction Update
August 11, 2022
Appointment of Joint Broker
July 20, 2022
Commencement of Trading on US OTCQB Venture Market
July 15, 2022
Result of AGM
June 30, 2022
Update on Acquisition of Oncogeni and Placing
June 23, 2022
Issue of Warrants
June 22, 2022
Notice of AGM - Correction
June 13, 2022
Pre-clinical Update
June 7, 2022
Annual Report & Financial Statements
May 11, 2022
Non-Executive Director Appointment
April 20, 2022
Board Appointment
April 5, 2022
Patent Filed - New Drug Class Targeting Midkine
March 21, 2022
Appointment of Strategic & Scientific Advisor
February 14, 2022
Price Monitoring Extension
January 18, 2022
Publication of New Research
January 10, 2022